Clopidogrel monotherapy is associated with higher mortality risk compared to aspirin: a retrospective analysis of NHANES 1999–2018
Background Clopidogrel and aspirin are widely used antiplatelet agents. Although clopidogrel resistance is more prevalent in Asian populations, a Korean study suggested that clopidogrel was superior to aspirin in patients who completed standard dual antiplatelet therapy following percutaneous corona...
Saved in:
| Main Authors: | Tieshi Zhu, Yong He, Yuzhang Bei, Hui Mai, Le Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Platelets |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09537104.2025.2532454 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anemia Increases All-Cause Mortality Risk in Stroke Survivors on Antiplatelet Therapy: A Retrospective Cohort Study
by: Tieshi Zhu, et al.
Published: (2025-04-01) -
Association of neutrophil-to-albumin ratio with all-cause and cardiovascular mortality in community-dwelling individuals with chronic kidney disease: evidence from the NHANES 1999–2018
by: Yu Han, et al.
Published: (2025-07-01) -
Association between compound dietary antioxidant index and all-cause and cancer mortality in patients with chronic obstructive pulmonary disease: results from NHANES 1999–2018
by: Wenqiang Li, et al.
Published: (2025-03-01) -
Impact of COPD and sarcopenia on all-cause and respiratory mortality in US adults: NHANES 1999–2018
by: Jiao Xu, et al.
Published: (2025-05-01) -
Endobronchial biopsies in patients receiving clopidogrel and aspirin treatment
by: Bilal Rabahoğlu, et al.
Published: (2025-07-01)